← Browse by Condition
Medical Condition

germline mutations

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT01994057
Recruiting

A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment

Enrollment
1,000 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →